EMA to review Pixuvri for NHL

The European Medicines Agency accepted for review an MAA from Cell Therapeutics Inc. (NASDAQ:CTIC; Milan:CTIC) for Pixuvri pixantrone to treat adult patients with relapsed or refractory aggressive non...